Testing effectiveness (Phase 2)Study completedNCT00322764
What this trial is testing
Phase II Study to Assess RG2417 in the Treatment of Bipolar I Depression
Who this might be right for
Bipolar Depression
Repligen Corporation 80
Showing 20 of 0 results